Chapter

British Society of Paediatric and Adolescent Rheumatology clinical guidelines and protocols

Edited by Helen Foster and Paul A. Brogan

in Paediatric Rheumatology

Published on behalf of Oxford University Press

Published in print June 2012 | ISBN: 9780199592630
Published online July 2012 | e-ISBN: 9780191740855 | DOI: http://dx.doi.org/10.1093/med/9780199592630.003.0009

Series: Oxford Specialist Handbooks

British Society of Paediatric             and Adolescent Rheumatology clinical guidelines and protocols

Show Summary Details

Preview

BSPAR Standards of Care for children and young people with JIA - BSPAR drug information leaflets for parents and families - BSPAR guidelines for treatments used in paediatric rheumatology - Non-steroidal anti-inflammatory drugs (NSAIDs) - Disease-modifying anti-rheumatic drugs (DMARDs) - Azathioprine - Ciclosporin - Intravenous cyclophosphamide - Pamidronate - Epoprostenol/iloprost - Etanercept (Enbrel®) - Other anti-TNF-α: adalimumab (Humira®) and infliximab (Remicade®) - Anti-IL-1 treatments: anakinra (Kineret®), rilonacept (Regeneron®), and canakinumab (Ilaris®) - Abatacept (Orencia®) - Anti-IL-6 treatment: tocilizumab (Ro-Actemra®) - Anti-B-cell therapies: rituximab (Mabthera®) - Systemic corticosteroids (oral, intramuscular, and intravenous) - Intra-articular corticosteroid use in JIA

Chapter.  9814 words.  Illustrated.

Subjects: Paediatrics ; Rheumatology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.